Bank of New York Mellon’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-89,199
| Closed | -$55.6K | – | 4122 |
|
|
2025
Q1 | $55.6K | Sell |
89,199
-804
| -0.9% | -$501 | ﹤0.01% | 4029 |
|
|
2024
Q4 | $150K | Buy |
90,003
+9,623
| +12% | +$16.1K | ﹤0.01% | 3973 |
|
|
2024
Q3 | $146K | Sell |
80,380
-24,586
| -23% | -$44.7K | ﹤0.01% | 3954 |
|
|
2024
Q2 | $633K | Buy |
104,966
+25,199
| +32% | +$152K | ﹤0.01% | 3441 |
|
|
2024
Q1 | $889K | Sell |
79,767
-6,539
| -8% | -$72.9K | ﹤0.01% | 3209 |
|
|
2023
Q4 | $1.29M | Buy |
86,306
+14,256
| +20% | +$212K | ﹤0.01% | 3059 |
|
|
2023
Q3 | $346K | Sell |
72,050
-40
| -0.1% | -$192 | ﹤0.01% | 3741 |
|
|
2023
Q2 | $541K | Buy |
72,090
+3,065
| +4% | +$23K | ﹤0.01% | 3539 |
|
|
2023
Q1 | $312K | Sell |
69,025
-634
| -0.9% | -$2.87K | ﹤0.01% | 3721 |
|
|
2022
Q4 | $785K | Sell |
69,659
-61
| -0.1% | -$687 | ﹤0.01% | 3319 |
|
|
2022
Q3 | $667K | Buy |
69,720
+6,620
| +10% | +$63.3K | ﹤0.01% | 3407 |
|
|
2022
Q2 | $510K | Sell |
63,100
-10,993
| -15% | -$88.9K | ﹤0.01% | 3570 |
|
|
2022
Q1 | $1.25M | Sell |
74,093
-4,201
| -5% | -$71K | ﹤0.01% | 3171 |
|
|
2021
Q4 | $1.68M | Sell |
78,294
-11,818
| -13% | -$254K | ﹤0.01% | 3092 |
|
|
2021
Q3 | $6.66M | Buy |
90,112
+17,510
| +24% | +$1.29M | ﹤0.01% | 2349 |
|
|
2021
Q2 | $3.97M | Buy |
72,602
+7,330
| +11% | +$401K | ﹤0.01% | 2598 |
|
|
2021
Q1 | $4.81M | Buy |
65,272
+5,698
| +10% | +$420K | ﹤0.01% | 2457 |
|
|
2020
Q4 | $5.14M | Buy |
59,574
+35,845
| +151% | +$3.09M | ﹤0.01% | 2345 |
|
|
2020
Q3 | $896K | Buy |
+23,729
| New | +$896K | ﹤0.01% | 3181 |
|